Amyris (AMRSQ) Azione Prezzo
Amyris Prezzo
Negli ultimi 17 anni Amyris ha aumentato il fatturato del 31,7% all'anno, raggiungendo 269,85 Mio. USD. Per Amyris, il margine netto del -195,9% risulta in aumento rispetto al -350,8% di alcuni anni fa.
Amyris Prezzo delle azioni
Amyris Azione e analisi azionaria
Domande frequenti sull'azione Amyris
Amyris Inc is a leading biotechnology company focused on sustainable ingredients for various industries. Their business model revolves around the production and commercialization of high-performance sustainable products. With a strong emphasis on innovation, Amyris utilizes its proprietary synthetic biology platform to engineer microbes and produce sustainable alternatives to petroleum-derived chemicals. These include renewable ingredients for cosmetics, fragrances, flavors, and nutraceuticals, as well as renewable feedstocks for the production of renewable diesel and jet fuels. By enabling the transition to a more sustainable economy, Amyris Inc aims to deliver environmental benefits while providing quality products to its customers.
Amyris Inc is primarily active in the renewable chemicals and sustainable fuels industries.
The main competitors of Amyris Inc in the market are Evolva Holding SA, Synthetic Genomics Inc, and Intrexon Corporation.
Amyris Inc. is a leading biotechnology company known for its sustainable solutions in the fields of health and wellness, clean beauty, and renewable chemicals. Founded in 2003, Amyris has a rich history marked by its commitment to advancements in synthetic biology. The company's groundbreaking research has enabled the production of a wide range of innovative products, including sustainable ingredients, fragrances, and high-performance materials. Amyris has collaborated with numerous partners and has expanded its global presence, ensuring the adoption of its renewable solutions worldwide. With a strong focus on environmental and societal well-being, Amyris Inc. continues to revolutionize industries through sustainable, nature-inspired innovations.
Amyris Inc has achieved several significant milestones in its trajectory. Notably, the company successfully developed and commercialized its proprietary yeast strain technology, enabling the production of high-value molecules more sustainably. Amyris Inc also established strategic partnerships with various global leaders, expanding its product portfolio and market reach. Additionally, the company made remarkable progress in the renewable energy sector, delivering renewable diesel and jet fuel solutions. Amyris Inc's commitment to sustainability and innovation has garnered accolades, including recognition as a Fast Company Most Innovative Company and a World Economic Forum Technology Pioneer. The company's continuous growth and advancements solidify its position as an industry leader in sustainable solutions.
Amyris Inc is primarily present in countries and regions across the globe, including the United States, Brazil, Europe, and Asia.
Amyris Inc represents a set of core values and corporate philosophy that drive its business operations. The company is committed to delivering sustainable solutions through its advanced biotechnology platform. Amyris focuses on providing renewable products across various industries, including clean beauty, flavors, fragrances, and sweeteners. With an emphasis on innovation, Amyris strives to create high-performance products, enhancing the quality of life while minimizing the environmental impact. The company's dedication to scientific excellence, integrity, and social responsibility enables Amyris to fulfill its mission of positively transforming the world. Amyris Inc consistently pursues its goal of sustainable development and improving global resource efficiency through innovative biotechnology solutions.
8 analisti valutano attualmente l’azione Amyris: 0 raccomandano l’acquisto, 3 la tenuta e 5 la vendita.
Convertita al tasso di cambio attuale, l’azione Amyris quota 0,00 EUR (0,00 USD).
L’azione Amyris (AMRSQ) è quotata su 5 borse, tra cui: NASDAQ (AMRS), SIX (Zürich) (3A01.SW), Frankfurt (3A01.F), München (3A01.MU), Düsseldorf (3A01.DU).
Amyris Inc. is an American biotechnology company based in Emeryville, California. Founded in 2003, the company specializes in the development and production of molecules that can serve as the basis for a variety of products, particularly in the cosmetics, skincare, body and hair care, perfume, and fragrance industries. Amyris Inc.'s business model is based on the use of innovative biotechnology platforms for the construction and optimization of microorganisms capable of producing specific molecules, such as essential oils, fats and waxes, sugars, flavors, and other compounds, from sustainable raw materials. The company's focus is on producing molecules from renewable resources such as sugarcane, corn, cellulose, and other bio-based materials. The molecules produced by Amyris are used either directly as end products or as ingredients in other products. Amyris has several divisions, including "Ingredients," "Cosmetics & Personal Care," "Fragrances & Flavors," and "Sweeteners & Nutraceuticals." In the "Ingredients" division, the company produces a variety of molecules that can be used as starting materials for the production of cosmetics and personal care products, cleaning agents, lubricants, and other products. Examples of products include squalene, hyaluronic acid, vitamin E, ferulic acid, caprylic/capric triglycerides, and others. In the "Cosmetics & Personal Care" division, Amyris also offers its own skincare, body, and hair care products based on sustainable, organic ingredients. These include nourishing facial oils, moisturizers, cleansers, shampoos, conditioners, and others. In the "Fragrances & Flavors" division, Amyris produces essential oils, flavors, and fragrances that are used in a variety of applications, including perfumes, room fragrances, scented candles, and aromatherapy products. Key products include lavender oil, cinnamon bark oil, lemon oil, vanillin, and others. Finally, Amyris also offers products in the "Sweeteners & Nutraceuticals" category, including plant-based sweeteners such as rebaudioside A and others, as well as dietary supplements based on omega-3 fatty acids, vitamin D3, and other ingredients. Amyris Inc.'s business model is based on the use of innovative biotechnology platforms for the development and production of molecules that can be used as raw materials for a variety of products. By using sustainable raw materials and producing molecules in an environmentally friendly way, the company has established itself as a pioneer in sustainable chemistry. With a wide range of products and a strong presence in global markets, Amyris Inc. is well positioned to continue growing in the coming years and promote awareness of sustainable innovations in the chemical industry.
Il fatturato non può essere attualmente calcolato per Amyris.
Il profitto per Amyris non può essere attualmente calcolato.
Il P/E per Amyris non può essere attualmente calcolato.
L'indicatore Price-to-Sales (P/S) per Amyris non può essere calcolato al momento.
Il Quality Score AlleAktien per Amyris è 4/10.
L'ISIN di Amyris è US03236M2008. L'ISIN (International Securities Identification Number) è un codice identificativo univoco a livello mondiale per i titoli.
Il WKN di Amyris è A2DS41. Il WKN (Wertpapierkennnummer) è un codice identificativo tedesco a sei cifre per i titoli.
Il ticker di Amyris è AMRSQ. Con questo simbolo di borsa vengono negoziate le azioni Amyris in borsa.
Azione Amyris
Gruppo di pari di Amyris
Amyris Ticker
Amyris FIGI
Altre metriche e analisi di Amyris in Deep Dive.
La nostra analisi azionaria dell'azione Amyris include importanti indicatori finanziari come il fatturato, l'utile, il P/E, il P/S, l'EBIT, oltre a informazioni sul dividendo. Inoltre, esaminiamo aspetti come le azioni, la capitalizzazione di mercato, il debito, il patrimonio netto e le passività di Amyris. Se state cercando informazioni più dettagliate su questi temi, sulle nostre sottopagine offriamo analisi approfondite: